Ibuprofen 250 mg / Acetaminophen 500 mg + Ibuprofen 250 mg + Acetaminophen 650 mg + Placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Post-surgical Pain Following Extraction of Molar Teeth
Conditions
Post-surgical Pain Following Extraction of Molar Teeth
Trial Timeline
Sep 1, 2015 → Jun 1, 2016
NCT ID
NCT02912650About Ibuprofen 250 mg / Acetaminophen 500 mg + Ibuprofen 250 mg + Acetaminophen 650 mg + Placebo
Ibuprofen 250 mg / Acetaminophen 500 mg + Ibuprofen 250 mg + Acetaminophen 650 mg + Placebo is a phase 3 stage product being developed by Pfizer for Post-surgical Pain Following Extraction of Molar Teeth. The current trial status is completed. This product is registered under clinical trial identifier NCT02912650. Target conditions include Post-surgical Pain Following Extraction of Molar Teeth.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02912650 | Phase 3 | Completed |
Competing Products
5 competing products in Post-surgical Pain Following Extraction of Molar Teeth
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Celecoxib | Astellas Pharma | Pre-clinical | 23 |
| valdecoxib + valdecoxib/placebo + placebo | Pfizer | Phase 3 | 76 |
| PF-04531083 + PF-04531083 + Ibuprofen | Pfizer | Phase 2 | 51 |
| Dexamethasone | Ocular Therapeutix | Phase 3 | 72 |
| Dexamethasone | Ocular Therapeutix | Phase 3 | 72 |